Abstract
Colorectal cancer remains a significant cause of morbidity and mortality. Treatment options and therapeutic interventions for patients who have disease progression despite treatment with systemic therapies have not been clearly established. However, yttrium-90 radioembolization may be useful as a minimally invasive liver-directed therapy. Although there are no large randomized controlled studies that specifically establish the role of radioembolization in this patient population, numerous studies have shown favorable toxicity and efficacy profiles and promising overall survival.
Similar content being viewed by others
References and Recommended Reading
Jemal A, Siegel R, Ward E, et al.: Cancer statistics, 2008. CA Cancer J Clin 2008, 58:71–96.
Sasson AR, Sigurdson ER: Surgical treatment of liver metastases. Semin Oncol 2002, 29:107–118.
Salem R, Thurston KG: Radioembolization with 90Yttrium microspheres: a state-of-the-art brachytherapy treatment for primary and secondary liver malignancies: part 1: technical and methodologic considerations. J Vasc Interv Radiol 2006, 17:1251–1278. [Published erratum appears in J Vasc Interv Radiol 2006, 17:1594.
Lewandowski RJ, Sato KT, Atassi B, et al.: Radioembolization with 90Y microspheres: angiographic and technical considerations. Cardiovasc Intervent Radiol 2007, 30:571–592.
Liu DM, Salem R, Bui JT, et al.: Angiographic considerations in patients undergoing liver-directed therapy. J Vasc Interv Radiol 2005, 16:911–935.
Salem R: Radioembolization with 90Y microspheres: technical considerations. J Vasc Interv Radiol 2007, 18:1460–1461.
Yu AS, Keeffe EB: Management of hepatocellular carcinoma. Rev Gastroenterol Disord 2003, 3:8–24.
Salem R, Thurston KG, Carr BI, et al.: Yttrium-90 microspheres: radiation therapy for unresectable liver cancer. J Vasc Interv Radiol 2002, 13(9 Pt 2):S223–S229.
Rhee TK, Omary RA, Gates V, et al.: The effect of catheter-directed CT angiography on yttrium-90 radioembolization treatment of hepatocellular carcinoma. J Vasc Interv Radiol 2005, 16:1085–1091.
Lewandowski RJ, Sato KT, Atassi B, et al.: Radioembolization with 90Y microspheres: angiographic and technical considerations. Cardiovasc Intervent Radiol 2007, 30:571–592.
Kim HC, Chung JW, Lee W, et al.: Recognizing extrahepatic collateral vessels that supply hepatocellular carcinoma to avoid complications of transcatheter arterial chemoembolization. Radiographics 2005, 25(Suppl 1):S25–S39.
Murthy R, Nunez R, Szklaruk J, et al.: Yttrium-90 microsphere therapy for hepatic malignancy: devices, indications, technical considerations, and potential complications. Radiographics 2005, 25(Suppl 1):S41–S55.
Sato KT, Omary RA, Ryu R, et al.: Radioembolization with yttrium-90 microspheres: angiographic and technical considerations. Tech Vasc Interv Radiol 2007, 10:12–29.
Ho S, Lau WY, Leung TW, et al.: Partition model for estimating radiation doses from yttrium-90 microspheres in treating hepatic tumours. Eur J Nucl Med 1996, 23:947–952.
Ho S, Lau WY, Leung TW, et al.: Clinical evaluation of the partition model for estimating radiation doses from yttrium-90 microspheres in the treatment of hepatic cancer. Eur J Nucl Med 1997, 24:293–298.
Salem R, Parikh P, Atassi B, et al.: Incidence of radiation pneumonitis after hepatic intra-arterial radiotherapy with yttrium-90 microspheres assuming uniform lung distribution. Am J Clin Oncol 2008, 31:431–438.
Salem R, Lewandowski RJ, Sato KT, et al.: Technical aspects of radioembolization with 90Y microspheres. Tech Vasc Interv Radiol 2007, 10:12–29.
Salem R, Thurston KG: Radioembolization with 90yttrium microspheres: a state-of-the-art brachytherapy treatment for primary and secondary liver malignancies. Part 2: special topics. J Vasc Interv Radiol 2006, 17:1425–1439.
Gray B, Van Hazel G, Hope M, et al.: Randomised trial of SIR-Spheres plus chemotherapy vs. chemotherapy alone for treating patients with liver metastases from primary large bowel cancer. Ann Oncol 2001, 12:1711–1720.
Stubbs RS, Cannan RJ, Mitchell AW: Selective internal radiation therapy with 90yttrium microspheres for extensive colorectal liver metastases. J Gastrointest Surg 2001, 5:294–302.
Stubbs RS, Cannan RJ, Mitchell AW: Selective internal radiation therapy (SIRT) with 90Yttrium microspheres for extensive colorectal liver metastases. Hepatogastroenterology 2001, 48:333–337.
Van Hazel G, Blackwell A, Anderson J, et al.: Randomised phase 2 trial of SIR-Spheres plus fluorouracil/leucovorin chemotherapy versus fluorouracil/leucovorin chemotherapy alone in advanced colorectal cancer. J Surg Oncol 2004, 88:78–85.
Van Hazel G, Price D, Bower G, et al.: Selective internal radiation therapy (SIRT) for liver metastases with concomitant systemic oxaliplatin, 5-fluorouracil and folinic acid: a phase I/II dose escalation study. ASCO Annual Meeting Proceedings; 2005. Abstract 3657.
Goldstein D, Van Hazel G, Pavlakis N, Olver I: Selective Internal Radiation therapy (SIRT) plus systemic chemotherapy with Irinotecan: A phase I dose escalation study. ASCO Annual Meeting Proceedings; 2005. Abstract 3701.
Sharma RA, Van Hazel GA, Morgan B, et al.: Radioembolization of liver metastases from colorectal cancer using yttrium-90 microspheres with concomitant systemic oxaliplatin, fluorouracil, and leucovorin chemotherapy. J Clin Oncol 2007, 25:1099–1106.
Kennedy AS, Coldwell D, Nutting C, et al.: Resin 90Ymicrosphere brachytherapy for unresectable colorectal liver metastases: modern USA experience. Int J Radiat Oncol Biol Phys 2006, 65:412–425.
Mulcahy MF, Lewandowski RJ, Ibrahim SM, et al.: Radioembolization of colorectal hepatic metastases using yttrium-90 microspheres. Cancer 2009 (in press).
Jakobs TF, Hoffmann RT, Dehm K, et al.: Hepatic yttrium-90 radioembolization of chemotherapy-refractory colorectal cancer liver metastases. J Vasc Interv Radiol 2008, 19:1187–1195.
Sato KT, Lewandowski RJ, Mulcahy MF, et al.: Unresectable chemorefractory liver metastases: radioembolization with 90Y microspheres—safety, efficacy, and survival. Radiology 2008, 247:507–515.
Messersmith W, Laheru D, Hidalgo M: Recent advances in the pharmacological treatment of colorectal cancer. Expert Opin Investig Drugs 2003, 12:423–434.
Hoff PM: Future directions in the use of antiangiogenic agents in patients with colorectal cancer. Semin Oncol 2004, 31:17–21.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Ibrahim, S.M., Riaz, A., Lewandowski, R.J. et al. Internal radioembolization for colorectal carcinoma liver metastases. Curr colorectal cancer rep 5, 93–98 (2009). https://doi.org/10.1007/s11888-009-0014-9
Published:
Issue Date:
DOI: https://doi.org/10.1007/s11888-009-0014-9